Long Term Use of Pegvisomant For A Regulatory Post Marketing Commitment Plan
Print
Written by
ClinicalTrials.gov
Category:
Bone diseases
Published: 09 April 2008
Condition
: Acromegaly
Intervention
: Drug: Pegvisomant
Sponsor
: Pfizer
Enrolling by invitation
- verified August 2011
Details
Last Updated: 09 April 2008